CADILLAC FORMULA 1® TEAM WELCOMES VIATRIS AS OFFICIAL GLOBAL PHARMACEUTICAL PARTNER
'UK Drugmaker in Talks to Boost Estrogen Patch Supply in US' - Bloomberg
Viatris Named to Fortune's World's Best Workplaces™ List for Second Consecutive Year
Viatris to Participate in Upcoming Investor Conferences
Viatris Inc. (VTRS) Hit a 52 Week High, Can the Run Continue?
VTRS Q3 2026 deep dive: new product launches and Pacira acquisition shape outlook
Viatris (VTRS) Stock May Be Below Fair Value Despite A $1.65B Deal
Viatris (VTRS) Earnings Beat And Higher Outlook Put Fair Value Back In Focus
Are Wall Street Analysts Predicting Viatris Stock Will Climb or Sink?
Viatris Inc (VTRS) (Q3 2026) Earnings Call Highlights: Raised Guidance, Pacira Deal and Supply ...
Viatris Inc. Q3 2026 Earnings Call Summary
Viatris (VTRS) Q3 2026 Earnings Call Transcript
Here's What Key Metrics Tell Us About Viatris (VTRS) Q3 Earnings
This Former Mylan/Pfizer Combo Just Topped Its Buy Zone — What You Should Know
Viatris Q3 Earnings Beat on Stronger Margins, Revenues Fall Y/Y
Viatris (NASDAQ:VTRS) misses Q3 2026 sales expectations but beats adjusted EPS consensus estimates
Viatris (NASDAQ:VTRS) Q3 2026 Earnings: Profit Beat Offset by Revenue Miss
Viatris Inc. (VTRS) Q3 2026 Earnings Call Transcript
Viatris: Q3 Earnings Snapshot
Viatris (VTRS) Q3 Earnings Beat Estimates
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.